<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 09, 2023</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05797181</url>
  </required_header>
  <id_info>
    <org_study_id>ABDemirbasPD</org_study_id>
    <nct_id>NCT05797181</nct_id>
  </id_info>
  <brief_title>The Effect Of Medical Nutritional Therapy On Patients With Sarcopenic Obesity Requesting Peritone Dialysis Treatment</brief_title>
  <official_title>The Effect of Medical Nutrition Therapy on Anthropometric Measurements and Blood Parameters in Sarcopenic Obesity Patients Undergoing Peritoneal Dialysis Treatment</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Atlas University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Atlas University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, it was aimed to evaluate the effectiveness of medical nutrition therapy to be&#xD;
      applied to patients with sarcopenic obesity receiving peritoneal dialysis treatment by&#xD;
      measuring anthropometric measurements and blood parameters.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 7, 2023</start_date>
  <completion_date type="Anticipated">May 15, 2023</completion_date>
  <primary_completion_date type="Anticipated">May 8, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in muscle strength</measure>
    <time_frame>Baseline to 3 months after diet programme</time_frame>
    <description>Handgrip strength (kg) will be measured by using the CAMRY EH101 dynamometer. Hand grip strength &lt;16 kg for women and &lt;27 kg for men indicates low muscle strength.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the skeletal muscle mass</measure>
    <time_frame>Baseline to 3 months after diet programme</time_frame>
    <description>Skeletal muscle mass (kg) will be measured by using bioelectrical impedance analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in the physical performance</measure>
    <time_frame>Baseline to 3 months after diet programme</time_frame>
    <description>4-meter walking speed test will be performed. A walking speed of ≤0.8 m/sec is considered as an indicator of severe sarcopenia.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Change of the fat mass</measure>
    <time_frame>Baseline to 3 months after diet programme</time_frame>
    <description>Fat mass (kg) will be measured by using bioelectrical impedance analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of percentage of body fat</measure>
    <time_frame>Baseline to 3 months after diet programme</time_frame>
    <description>Percentage of body fat will be measured by using bioelectrical impedance analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Changes of body mass index</measure>
    <time_frame>Baseline to 3 months after diet programme</time_frame>
    <description>The weight and height will be combined to report BMI in kg/m2.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">15</enrollment>
  <condition>Peritoneal Dialysis Complication</condition>
  <condition>Sarcopenic Obesity</condition>
  <arm_group>
    <arm_group_label>Dietary and Behavioral Change Group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The experimental group will be required to adhere to a diet consisting of a 10-15% reduction in carbohydrate and a 1.2-1.4 g/kg body weight/day intake of protein.&#xD;
The participants will receive 4 times face-to-face meetings (on the first day and on week 1,5 and 9).&#xD;
Each face-to-face interview will last approximately 30 minutes. During the interview researcher will help the participants to determine their nutritional behaviors, plan and implement the diet.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>medical nutrition therapy in kidney diseases</intervention_name>
    <description>Planning and implementation of diets containing high protein, low potassium, low phosphorus, personalized adjusted carbohydrates</description>
    <arm_group_label>Dietary and Behavioral Change Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Volunteering to participate in research&#xD;
&#xD;
          -  Be between the ages of 18-70&#xD;
&#xD;
          -  To receive peritoneal dialysis treatment and to come to the hospital regularly once a&#xD;
             month for treatment&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Presence of any other disease that causes muscle wasting&#xD;
&#xD;
          -  Patients using any supplement or enteral product in their diet&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ayşe Betül Demirbaş</last_name>
    <phone>+902124443439</phone>
    <email>betulldemirbas@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Marmara University</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ayşe Betül Demirbaş</last_name>
      <phone>+902124443439</phone>
      <email>betulldemirbas@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>March 2023</verification_date>
  <study_first_submitted>February 24, 2023</study_first_submitted>
  <study_first_submitted_qc>March 21, 2023</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2023</study_first_posted>
  <last_update_submitted>March 21, 2023</last_update_submitted>
  <last_update_submitted_qc>March 21, 2023</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2023</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Atlas University</investigator_affiliation>
    <investigator_full_name>Ayşe Betül Demirbaş</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

